277 related articles for article (PubMed ID: 25246269)
1. Sall4 overexpression blocks murine hematopoiesis in a dose-dependent manner.
Milanovich S; Peterson J; Allred J; Stelloh C; Rajasekaran K; Fisher J; Duncan SA; Malarkannan S; Rao S
Exp Hematol; 2015 Jan; 43(1):53-64.e1-8. PubMed ID: 25246269
[TBL] [Abstract][Full Text] [Related]
2. SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic mice.
Ma Y; Cui W; Yang J; Qu J; Di C; Amin HM; Lai R; Ritz J; Krause DS; Chai L
Blood; 2006 Oct; 108(8):2726-35. PubMed ID: 16763212
[TBL] [Abstract][Full Text] [Related]
3. Enhanced self-renewal of hematopoietic stem/progenitor cells mediated by the stem cell gene Sall4.
Yang J; Aguila JR; Alipio Z; Lai R; Fink LM; Ma Y
J Hematol Oncol; 2011 Sep; 4():38. PubMed ID: 21943195
[TBL] [Abstract][Full Text] [Related]
4. Histone lysine-specific demethylase 1 (LSD1) protein is involved in Sal-like protein 4 (SALL4)-mediated transcriptional repression in hematopoietic stem cells.
Liu L; Souto J; Liao W; Jiang Y; Li Y; Nishinakamura R; Huang S; Rosengart T; Yang VW; Schuster M; Ma Y; Yang J
J Biol Chem; 2013 Nov; 288(48):34719-28. PubMed ID: 24163373
[TBL] [Abstract][Full Text] [Related]
5. Runx1 isoforms show differential expression patterns during hematopoietic development but have similar functional effects in adult hematopoietic stem cells.
Challen GA; Goodell MA
Exp Hematol; 2010 May; 38(5):403-16. PubMed ID: 20206228
[TBL] [Abstract][Full Text] [Related]
6. A SALL4/MLL/HOXA9 pathway in murine and human myeloid leukemogenesis.
Li A; Yang Y; Gao C; Lu J; Jeong HW; Liu BH; Tang P; Yao X; Neuberg D; Huang G; Tenen DG; Chai L
J Clin Invest; 2013 Oct; 123(10):4195-207. PubMed ID: 24051379
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of sPRDM16 coupled with loss of p53 induces myeloid leukemias in mice.
Shing DC; Trubia M; Marchesi F; Radaelli E; Belloni E; Tapinassi C; Scanziani E; Mecucci C; Crescenzi B; Lahortiga I; Odero MD; Zardo G; Gruszka A; Minucci S; Di Fiore PP; Pelicci PG
J Clin Invest; 2007 Dec; 117(12):3696-707. PubMed ID: 18037989
[TBL] [Abstract][Full Text] [Related]
8. Differential roles of Sall4 isoforms in embryonic stem cell pluripotency.
Rao S; Zhen S; Roumiantsev S; McDonald LT; Yuan GC; Orkin SH
Mol Cell Biol; 2010 Nov; 30(22):5364-80. PubMed ID: 20837710
[TBL] [Abstract][Full Text] [Related]
9. SALL4 is a key transcription regulator in normal human hematopoiesis.
Gao C; Kong NR; Li A; Tatetu H; Ueno S; Yang Y; He J; Yang J; Ma Y; Kao GS; Tenen DG; Chai L
Transfusion; 2013 May; 53(5):1037-49. PubMed ID: 22934838
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of HOXA10 perturbs human lymphomyelopoiesis in vitro and in vivo.
Buske C; Feuring-Buske M; Antonchuk J; Rosten P; Hogge DE; Eaves CJ; Humphries RK
Blood; 2001 Apr; 97(8):2286-92. PubMed ID: 11290589
[TBL] [Abstract][Full Text] [Related]
11. Leukemic survival factor SALL4 contributes to defective DNA damage repair.
Wang F; Gao C; Lu J; Tatetsu H; Williams DA; Müller LU; Cui W; Chai L
Oncogene; 2016 Nov; 35(47):6087-6095. PubMed ID: 27132514
[TBL] [Abstract][Full Text] [Related]
12. Ash1l controls quiescence and self-renewal potential in hematopoietic stem cells.
Jones M; Chase J; Brinkmeier M; Xu J; Weinberg DN; Schira J; Friedman A; Malek S; Grembecka J; Cierpicki T; Dou Y; Camper SA; Maillard I
J Clin Invest; 2015 May; 125(5):2007-20. PubMed ID: 25866973
[TBL] [Abstract][Full Text] [Related]
13. Regulation of hematopoietic stem cells using protein transduction domain-fused Polycomb.
Kajiume T; Sera Y; Kawahara Y; Matsumoto M; Fukazawa T; Imura T; Yuge L; Kobayashi M
Exp Hematol; 2012 Sep; 40(9):751-760.e1. PubMed ID: 22634509
[TBL] [Abstract][Full Text] [Related]
14. Role of SALL4 in hematopoiesis.
Yang J; Liao W; Ma Y
Curr Opin Hematol; 2012 Jul; 19(4):287-91. PubMed ID: 22555391
[TBL] [Abstract][Full Text] [Related]
15. Low-level GATA2 overexpression promotes myeloid progenitor self-renewal and blocks lymphoid differentiation in mice.
Nandakumar SK; Johnson K; Throm SL; Pestina TI; Neale G; Persons DA
Exp Hematol; 2015 Jul; 43(7):565-77.e1-10. PubMed ID: 25907033
[TBL] [Abstract][Full Text] [Related]
16. The stem cell factor SALL4 is an essential transcriptional regulator in mixed lineage leukemia-rearranged leukemogenesis.
Yang L; Liu L; Gao H; Pinnamaneni JP; Sanagasetti D; Singh VP; Wang K; Mathison M; Zhang Q; Chen F; Mo Q; Rosengart T; Yang J
J Hematol Oncol; 2017 Oct; 10(1):159. PubMed ID: 28974232
[TBL] [Abstract][Full Text] [Related]
17. Bmi1 confers resistance to oxidative stress on hematopoietic stem cells.
Nakamura S; Oshima M; Yuan J; Saraya A; Miyagi S; Konuma T; Yamazaki S; Osawa M; Nakauchi H; Koseki H; Iwama A
PLoS One; 2012; 7(5):e36209. PubMed ID: 22606246
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic transcription factor Evi1 regulates hematopoietic stem cell proliferation through GATA-2 expression.
Yuasa H; Oike Y; Iwama A; Nishikata I; Sugiyama D; Perkins A; Mucenski ML; Suda T; Morishita K
EMBO J; 2005 Jun; 24(11):1976-87. PubMed ID: 15889140
[TBL] [Abstract][Full Text] [Related]
19. Polycomb group ring finger 1 cooperates with Runx1 in regulating differentiation and self-renewal of hematopoietic cells.
Ross K; Sedello AK; Todd GP; Paszkowski-Rogacz M; Bird AW; Ding L; Grinenko T; Behrens K; Hubner N; Mann M; Waskow C; Stocking C; Buchholz F
Blood; 2012 May; 119(18):4152-61. PubMed ID: 22411870
[TBL] [Abstract][Full Text] [Related]
20. Bmi-1 is a target gene for SALL4 in hematopoietic and leukemic cells.
Yang J; Chai L; Liu F; Fink LM; Lin P; Silberstein LE; Amin HM; Ward DC; Ma Y
Proc Natl Acad Sci U S A; 2007 Jun; 104(25):10494-9. PubMed ID: 17557835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
